[EQ] IOM: A National Cancer Clinical Trials System for the 21st Century

A National Cancer Clinical Trials System for the 21st Century:
Reinvigorating the NCI Cooperative Group Program

 

Board on Health Care Services

US - Institute of Medicine IOM - April 15, 2010

Available online at: http://bit.ly/9wiksK

 

“……..Advances in biomedical research continue to create significant opportunities for improving cancer detection, treatment, and prevention. Clinical trials that test the safety and therapeutic benefit of promising treatments are essential in translat­ing new knowledge into tangible benefits for patients with cancer. For the past 50 years, the National Cancer Institute’s (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. ….

 

…..The IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research. The program should maintain a robust, standing cancer clinical trials network by preserving its histori­cal strengths while improving components that are not working well. Four overarching goals should guide improvement efforts:

 

- Improving the speed and efficiency of the design, launch, and conduct of clinical trials
- Making optimal use of scientific innovations
- Improving selection, prioritization, support, and completion of clinical trials
- Fostering expanded participation of both patients and physicians …………..”

 

Content:

Executive Summary

Overview of Conclusions and Recommendations  

1 Introduction  

2 The Science of Developing Cancer Therapy  

3 Operations, Oversight, and Funding of Cancer Clinical Trials  

4 Physician and Patient Participation in Cancer Clinical Trials  

Appendix A Previous and Ongoing Analyses  

Appendix B Committee Member and Staff Biographies  

Acronyms  

Glossary

 

 

*      *     *

This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues.  [DD/ KMC Area]

“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.
------------------------------------------------------------------------------------
PAHO/WHO Website
Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html
Twitter http://twitter.com/eqpaho

IMPORTANT: This transmission is for use by the intended
recipient and it may contain privileged, proprietary or
confidential information. If you are not the intended
recipient or a person responsible for delivering this
transmission to the intended recipient, you may not
disclose, copy or distribute this transmission or take
any action in reliance on it. If you received this transmission
in error, please dispose of and delete this transmission. 

Thank you.